BMY

EquitiesLive

Tokenized Bristol-Myers Squibb

Tokenized Bristol-Myers Squibb, on-chain exposure to the underlying equity.

See BMY on /markets →Underlying ticker: BMY
Available onGM Markets

Key facts

On-chain symbol
BMY
Underlying
BMY
Asset class
Equities
Custody
Held at Flo Finance
Chains
Base, Arbitrum, Ethereum
Distribution treatment
Total return, accrued to NAV
Attestation cadence
Daily
Issuer
Flo Finance
Backing
1:1 backed by the real underlying

How BMY resolves to BMY

Each BMY on-chain represents a 1:1 claim on the underlying Bristol-Myers Squibb held at an institutional custodian. The issuer and backing model are the same for every Flo token; only the underlying differs.

  1. 01

    Issuance

    Flo Finance issues BMY as a tokenized Bristol-Myers Squibb, 1:1 backed by the real underlying.

  2. 02

    Custody

    The underlying Bristol-Myers Squibb is held at Flo Finance, an institutional custodian.

  3. 03

    Settlement

    BMY settles on-chain on Base, Arbitrum, Ethereum. Cross-chain transfers route through Chainlink CCIP.

  4. 04

    Attestation

    Reserves are attested daily by an independent auditor and published on the Flo transparency surface.

Mint BMY with one SDK call

Every Flo-issued token shares the same six SDK methods. Mint, redeem, supply, withdraw, borrow, repay.

POST /v1/mint

{
  "asset": "BMY",
  "notional_usdc": "1000.00",
  "slippage_bps": 50,
  "settlement": {
    "currency": "USDC",
    "chain": "base"
  }
}

Where BMY lives today

Flo distributes through partners. The same BMY on-chain is the asset every partner integrates against; partner UIs may relabel it for their own brand.

Available on BMY

1 partner

See the asset live, in a real partner app, settled on-chain through the Flo SDK.

Audits

Four independent firms, $250K bug bounty

Sherlock, Halborn, Cantina, and Cyfrin have audited the smart contracts that issue and settle BMY. The same contracts power every Flo-issued token; one audit covers the catalogue.

Read the audit reports →

Backing

1:1 backed by the real underlying

BMY is issued by Flo Finance and 1:1 backed by real Bristol-Myers Squibb held at institutional custodians. Reserves are attested daily and published on the Flo transparency surface.

Open the transparency page →

Risks

BMY carries the market risk of the underlying Bristol-Myers Squibb, plus the structural risks common to every tokenized asset: custody concentration, smart-contract risk, and oracle dependency. Read the full risk disclosures on the Flo transparency surface before integrating or holding.